[Evaluating the efficacy of interferon therapy on hepatitis C patients].
Shiraha
Hidenori
H
Department of Medicine and Medical Science, Okayama University Graduate School of Medicine and Dentistry.
Iwasaki
Yoshiaki
Y
Shiratori
Yasushi
Y
D000998:Antiviral Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D006528:Carcinoma, Hepatocellular / Q000209:etiology / Q000517:prevention & control; D004359:Drug Therapy, Combination; D005355:Fibrosis; D005500:Follow-Up Studies; D016174:Hepacivirus / Q000235:genetics; D006526:Hepatitis C / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D008099:Liver / Q000473:pathology; D008113:Liver Neoplasms / Q000209:etiology / Q000517:prevention & control; D016133:Polymerase Chain Reaction; D012367:RNA, Viral / Q000097:blood; D012254:Ribavirin / Q000627:therapeutic use; D016896:Treatment Outcome
D000998:Antiviral Agents; D015415:Biomarkers; D012367:RNA, Viral; D012254:Ribavirin; D007372:Interferons